Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Hugo Fuentes"'
Autor:
Luis Piedra-Delgado, Diego Chambergo-Michilot, Zaida Morante, Carlos Fairen, Fernando Jerves-Coello, Renato Luque-Benavides, Fresia Casas, Eduarda Bustamante, Cesar Razuri-Bustamante, J Smith Torres-Roman, Hugo Fuentes, Henry Gomez, Alexis Narvaez-Rojas, Gabriel De la Cruz-Ku, Jhajaira Araujo
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0293833 (2024)
BackgroundEvidence regarding differences in survival associated with the site of metastasis in triple-negative breast cancer (TNBC) remains limited. Our aim was to analyze the overall survival (OS), distant relapse free survival (DRFS), and survival
Externí odkaz:
https://doaj.org/article/6321aef16f9948409de08e0d6111df73
Autor:
Zaida Morante, Yomali Ferreyra, Joseph A. Pinto, Natalia Valdivieso, Carlos Castañeda, Tatiana Vidaurre, Guillermo Valencia, Patricia Rioja, Hugo Fuentes, José M. Cotrina, Silvia Neciosup, Henry L. Gomez
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionTriple-negative breast cancer (TNBC) is a heterogeneous disease associated with a poor prognosis. Delaying in time to start adjuvant chemotherapy (TTC) has been related to an increased risk of distant recurrence-free survival (DRFS). We a
Externí odkaz:
https://doaj.org/article/0b6db31af593472e98a30cc05c4d14f3
Autor:
Patricia Rioja, Guillermo Valencia, Zaida Morante, Roberto Paz, Heberth Vallejos, Hugo Fuentes, Silvia Neciosup
Publikováno v:
Acta Médica Peruana, Vol 39, Iss 1 (2022)
La quimioterapia neoadyuvante basada en cisplatino ha demostrado un claro beneficio en cáncer de vejiga músculo invasivo (MIBC) EC II o IIIA, logrando un impacto en la sobrevida libre de progresión y sobrevida global. Esta revisión actualizada se
Externí odkaz:
https://doaj.org/article/13d30af0db2544deaaa820de1b9b65ae
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 37, Iss 4, Pp 611-9 (2020)
Objetivo: El desarrollo de cuadros severos y la muerte por COVID-19 son más frecuentes en poblaciones con comorbilidades. Algunos estudios describen mayor frecuencia de cuadros severos en pacientes con cáncer. Esta revisión sistemática tiene por
Externí odkaz:
https://doaj.org/article/b15f78bf60e64d9687b239d7d6cc4570
Autor:
Selaya, N. Galia, Zuidema, Pieter A., Baraloto, Christopher, Vos, Vincent A., Brienen, Roel J. W., Pitman, Nigel, Brown, Foster, Duchelle, Amy E., Araujo-Murakami, Alejandro, Carillo, Luis A. Oliveira, Colomo, Guido H. Vasquez, Chupinagua, Severo Meo, Nay, Hugo Fuentes, Perz, Stephen
Publikováno v:
Ecology and Society, 2017 Jun 01. 22(2)
Externí odkaz:
https://www.jstor.org/stable/26270138
Autor:
Miguel Martín, Andrew K. Godwin, Bruce F. Kimler, Roy A. Jensen, Jaimie Heldstab, Anne P. O’Dea, Amanda L. Amin, Jamie L. Wagner, Joshua V. Mammen, Jennifer R. Klemp, Yen Y. Wang, Carolyn Lehn, Charles M. Perou, Iván Márquez-Rodas, Denisse Bretel Morales, Hugo Fuentes-Rivera, Javier Cortés, Ricardo González del Val, María Isabel Palomero, Beatriz Pelaez-Lorenzo, Tatiana Massarrah, Milagros González-Rivera, María del Monte-Millán, Antoni C. Picornell, Agustí Barnadas, Yolanda Jerez-Gilarranz, Fernando Moreno, Aleix Prat, Henry L. Gómez, Qamar J. Khan, José Angel García-Saenz, Sara López-Tarruella, Priyanka Sharma
Purpose:Prognostic value of pathologic complete response (pCR) and extent of pathologic response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) is unknown. We report recurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0a1a1ee8be5e76e560e64a45c6977d
https://doi.org/10.1158/1078-0432.c.6527297.v1
https://doi.org/10.1158/1078-0432.c.6527297.v1
Autor:
Miguel Martin, Charles M. Perou, Uriel Bohn, Ana Isabel Ballesteros, Agusti Barnadas, Hugo Fuentes, María Cebollero, Inmaculada Ocaña, Tatiana Massarrah, Javier Gayarre, Rocío Ramos-Medina, Enrique Alvarez, Iván Márquez-Rodas, María Del Monte-Millan, Fernando Moreno, Henry L. Gómez, Katherine Hoadley, Yolanda Jerez, Jose Ángel García-Saenz, Antoni Picornell, Sara López-Tarruella, Isabel Echavarria
Purpose: Triple-negative breast cancer (TNBC) requires the iden- tification of reliable predictors of response to neoadjuvant chemotherapy (NACT). For this purpose, we aimed to evaluate the performance of the TNBCtype-4 classifier in a cohort of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32104e461530252039a0a9900266619d
https://doi.org/10.1158/1078-0432.c.6525846
https://doi.org/10.1158/1078-0432.c.6525846
Autor:
Miguel Martín, Andrew K. Godwin, Bruce F. Kimler, Roy A. Jensen, Jaimie Heldstab, Anne P. O’Dea, Amanda L. Amin, Jamie L. Wagner, Joshua V. Mammen, Jennifer R. Klemp, Yen Y. Wang, Carolyn Lehn, Charles M. Perou, Iván Márquez-Rodas, Denisse Bretel Morales, Hugo Fuentes-Rivera, Javier Cortés, Ricardo González del Val, María Isabel Palomero, Beatriz Pelaez-Lorenzo, Tatiana Massarrah, Milagros González-Rivera, María del Monte-Millán, Antoni C. Picornell, Agustí Barnadas, Yolanda Jerez-Gilarranz, Fernando Moreno, Aleix Prat, Henry L. Gómez, Qamar J. Khan, José Angel García-Saenz, Sara López-Tarruella, Priyanka Sharma
Pathological response to carboplatin plus docetaxel by germline BRCA status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0767bda7352f9a9520ddbf3d324bdcc9
https://doi.org/10.1158/1078-0432.22469603
https://doi.org/10.1158/1078-0432.22469603
Autor:
Miguel Martin, Qamar J. Khan, Bruce F. Kimler, Roy A. Jensen, Andrew K. Godwin, Jaimie Heldstab, Carol J. Fabian, Amanda L. Amin, Jennifer R. Klemp, Marilee K. McGinness, Joshua M.V. Mammen, Jamie L. Wagner, Charles M. Perou, Iván Márquez-Rodas, Denisse Bretel Morales, Hugo Fuentes Rivera, Javier Cortes, Ricardo González del Val, María Isabel Palomero, Beatriz Pelaez-Lorenzo, Tatiana Massarrah, Milagros Gonzalez-Rivera, Maria del Monte-Millán, Antoni C. Picornell, Augusti Barnadas, Yolanda Jerez-Gilarranz, Fernando Moreno, Aleix Prat, Henry L. Gómez, Carol S. Connor, Claire Ward, Jose Angel García-Saenz, Sara López-Tarruella, Priyanka Sharma
Purpose: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin to anthracycline/taxane chemotherapy improves pathologic complete response (pCR) in triple-negative breast cancer (TNBC). Effectiveness of anthracycline-free platinum c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a15be7bafdd234b05a5858647d4025
https://doi.org/10.1158/1078-0432.c.6525104
https://doi.org/10.1158/1078-0432.c.6525104
Autor:
Miguel Martin, Charles M. Perou, Uriel Bohn, Ana Isabel Ballesteros, Agusti Barnadas, Hugo Fuentes, María Cebollero, Inmaculada Ocaña, Tatiana Massarrah, Javier Gayarre, Rocío Ramos-Medina, Enrique Alvarez, Iván Márquez-Rodas, María Del Monte-Millan, Fernando Moreno, Henry L. Gómez, Katherine Hoadley, Yolanda Jerez, Jose Ángel García-Saenz, Antoni Picornell, Sara López-Tarruella, Isabel Echavarria
Table S1 Response among mutation carriers among mutation carriers (number of patients.)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa94e7ffdbda3afa5b39c7901641c0b
https://doi.org/10.1158/1078-0432.22464876
https://doi.org/10.1158/1078-0432.22464876